Taylor Frigon Capital Management’s Myriad Genetics MYGN Stock Holding History

Taylor Frigon Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50,745	Closed	-$1.38M	–	89
2019 Q4	$1.38M	Buy	50,745 +2,632	+5%	+$72.4K	0.95%	51
2019 Q3	$1.38M	Buy	48,113 +2,210	+5%	+$64.4K	1%	49
2019 Q2	$1.27M	Buy	45,903 +5,718	+14%	+$161K	0.88%	50
2019 Q1	$1.33M	Sell	40,185 -241	-0.6%	-$7.34K	1.04%	44
2018 Q4	$1.18M	Buy	40,426 +497	+1%	+$17.9K	1.03%	44
2018 Q3	$1.84M	Sell	39,929 -6,927	-15%	-$308K	1.39%	28
2018 Q2	$1.75M	Sell	46,856 -133	-0.3%	-$4.49K	1.27%	35
2018 Q1	$1.39M	Buy	46,989 +3,212	+7%	+$109K	1.08%	41
2017 Q4	$1.5M	Buy	+43,777	New	+$1.48M	1.21%	33
2016 Q2	$1.39M	Buy	45,341 +8,722	+24%	+$303K	1.45%	27
2016 Q1	$1.37M	Buy	36,619 +1,836	+5%	+$69.2K	1.45%	27
2015 Q4	$1.49M	Sell	34,783 -1,169	-3%	-$49.4K	1.67%	17
2015 Q3	$1.34M	Buy	35,952 +1,383	+4%	+$49.1K	1.49%	31
2015 Q2	$1.18M	Sell	34,569 -1,186	-3%	-$40.3K	1.22%	42
2015 Q1	$1.22M	Sell	35,755 -825	-2%	-$29.5K	1.13%	47
2014 Q4	$1.25M	Buy	+36,580	New	+$1.3M	1.17%	46

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Taylor Frigon Capital Management's MYGN Position: Q1 2020 in Review

Taylor Frigon Capital Management sold out of Myriad Genetics (MYGN) in Q1 2020, closing a stake of 50,745 shares — an estimated $1.38M sold.

Taylor Frigon Capital Management first reported a position in MYGN in Q4 2014 and held it in 16 quarters. The position peaked at $1.84M in Q3 2018. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2020.

Taylor Frigon Capital Management reported no remaining Myriad Genetics position as of Q1 2020 after selling out during the quarter.
Taylor Frigon Capital Management sold 50,745 Myriad Genetics shares in Q1 2020, an estimated $1.38M.
Taylor Frigon Capital Management first reported a position in Myriad Genetics in Q4 2014 and held it in 16 quarters.
Taylor Frigon Capital Management's Myriad Genetics position peaked at $1.84M in Q3 2018.
190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2020.

Based on Taylor Frigon Capital Management's 13F filing for Q1 2020, filed 24 Apr 2020.